Although KRAS mutations commonly have been reported among patients with S-CRC (18%-61%) and IBD-CRC/dysplasia (6%-50%) [21, 23, 33], KRAS mutation may occur later in IBD-CRC/dysplasia compared to S-CRC. Here, KRAS is linked to colorectal carcinoma.